FDA NDC Directory · JSON-LD · Markdown

Sildenafil Citrate

NDC 67877-648 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA212440
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsSILDENAFIL CITRATE (10 mg/mL)
Marketing started20191129
Package count1

External sources

Source: openFDA. Public-domain (CC0).